View of DOCETAXEL VERSUS DOCETAXEL PLUS CAPECITABINE AS NEOADJUVANT CHEMOTHERAPY FOR TRIPLE-NEGATIVE BREAST CANCER PATIENTS

Return to Article Details DOCETAXEL VERSUS DOCETAXEL PLUS CAPECITABINE AS NEOADJUVANT CHEMOTHERAPY FOR TRIPLE-NEGATIVE BREAST CANCER PATIENTS Download Download PDF